Ayala-Ramírez Paola, Serrano Natalia, Barrera Viviana, Bejarano Juan Pablo, Silva Jaime Luis, Martínez Rodolfo, Gil Fabian, Olaya-C Mercedes, García-Robles Reggie
Human Genetics Institute, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Research Seedbed in Perinatal Medicine Pontificia Universidad Javeriana: Medical School Pontificia Universidad Javeriana and Medical Residents Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia.
Heliyon. 2020 Sep 28;6(9):e05079. doi: 10.1016/j.heliyon.2020.e05079. eCollection 2020 Sep.
In Latin America and the Caribbean, hypertensive pregnancy disorders are responsible for almost 26% of all maternal deaths [1] and, in Colombia, they account for 59% of all severe maternal morbidity (SMM) cases, and 59.7% of all SMM cases in adolescents [2]. One of the most important hypertensive pregnancy disorders is preeclampsia (PE). Lives can be saved, if PE is prevented, or detected early and properly managed. Prevention and detection depend on identifying the risk factors associated with PE, and, as these have been shown vary by population, they should be determined on a population-by-population basis. The following study utilized the nested case-control model to evaluate 45 potential PE risk factors of a cohort in Bogotá, Colombia, making it perhaps the most comprehensive study of its kind in Colombia. It found PE to have a statistically significant association with 7 of the 45 factors evaluated: 1) pre-gestational BMI >30 kg/m, 2) pregnancy weight gain >12 kg, 3) previous history preeclampsia/eclampsia, 4) previous history of IUGR-SGA (Intrauterine Growth Restriction-Small for Gestational Age), 5) maternal age <20 or ≥35 years (20-34 was not associated), and 6) family history of diabetes. Finally, prenatal consumption of folic acid was found to lower the risk of PE. We recommend that, in Colombia, factors 1-6 be used to identify at risk mothers during pregnancy check-ups; that mothers be encouraged to take folic acid during pregnancy; and, that Colombia's health system and public policy address the problem of pregestational obesity.
在拉丁美洲和加勒比地区,妊娠高血压疾病导致了近26%的孕产妇死亡[1],而在哥伦比亚,它们占所有严重孕产妇发病(SMM)病例的59%,在青少年所有SMM病例中占59.7%[2]。最重要的妊娠高血压疾病之一是子痫前期(PE)。如果子痫前期能够得到预防、早期发现并妥善管理,就能挽救生命。预防和检测取决于识别与子痫前期相关的风险因素,而且,由于这些因素已显示因人群而异,所以应该逐人群确定。以下研究利用巢式病例对照模型评估了哥伦比亚波哥大一队列中的45个潜在子痫前期风险因素,这可能是哥伦比亚同类研究中最全面的一项。研究发现,子痫前期与所评估的45个因素中的7个存在统计学显著关联:1)孕前体重指数>30kg/m²,2)孕期体重增加>12kg,3)子痫前期/子痫病史,4)宫内生长受限-小于胎龄儿(IUGR-SGA)病史,5)母亲年龄<20岁或≥35岁(20-34岁无关联),6)糖尿病家族史。最后,发现孕期服用叶酸可降低子痫前期风险。我们建议,在哥伦比亚,利用因素1-6在孕期检查时识别高危母亲;鼓励母亲在孕期服用叶酸;并且,哥伦比亚的卫生系统和公共政策应解决孕前肥胖问题。